AdvaMed Archives - Page 7 of 7 - Medical Design Sourcing

Advamed: Diagnostic COVID-19 tests shipments hit 1m

U.S. shipments of COVID-19 molecular diagnostic tests reached 1 million per day for the week ending July 24, based on the latest data from AdvaMed’s national testing registry.

The medtech trade group launched the registry July 21 to aid state and federal pandemic responses.

“This incredible milestone is just the latest example of how the medical technology industry is rising to meet the challenges posed by the COVID-19 pandemic,” said AdvaMed president & CEO Scott Whitaker in a news release. “Widespread and widely available testing is key to our ability as a nation to overcome this public health crisis, and our industry is committed to providing the testing supplies and information health care providers need in order to achieve the necessary testing capacity.”

Get the full story on our sister site, Medical Design & Outsourcing.

AdvaMed unveils COVID-19 diagnostic supply registry

AdvaMed announced today that it created a comprehensive national COVID-19 diagnostic supply registry to aid state and federal pandemic responses.

According to a news release, AdvaMed is launching the registry in partnership with 13 commercial diagnostics manufacturers: Abbott (NYSE:ABT), Becton Dickinson (NYSE:BDX), bioMérieux, Bio-Rad Laboratories (NYSE:BIO), Beckman Coulter, Cepheid, Hologic (NSDQ:HOLX), Ortho Clinical Diagnostics, Qiagen (NYSE:QGEN), Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers (ETR: SHL), and Thermo Fisher Scientific (NYSE:TMO).

The AdvaMed registry is designed to compile information from the diagnostic companies, along with public data, to create a centralized and standardized COVID-19 diagnostic supply registry to update on weekly numbers at state and national levels regarding molecular, antigen and serology tests shipped in the U.S.

AdvaMed said in the release that the registry will also help streamline communicati…

CVRx’s Yared speaks to the value of confidence and cooperation

Nadim Yared, CEO of CVRx

This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.

The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.

In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.

Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college.

In this talk, Yared speaks to several issues including:

The power of confidence and the dangers of overconfidence when building a career. How he decided to take the job at CVRx (and why he didn’t initially want to talk abo…

340 organizations ask Congress for telehealth to stay

Today, 340 companies signed a letter sent to Congress to urge leaders to make COVID-19-related telehealth flexibilities permanent.

Representing all 50 states, Washington, D.C., and Puerto Rico, the signees are seeking to stop the potential for telehealth flexibilities to disappear, should Congress fail to act before the COVID-19 public health emergency expires, according to a news release.

At the beginning of the pandemic, Congress waived statutory barriers to allow for expanded access to telehealth, offering federal agencies the flexibility to allow healthcare providers to deliver care virtually. The letter says that those flexibilities will immediately go away if Congress doesn’t act.

The 340 stakeholders who signed the letter urged Congress to remove obsolete restrictions on the location of the patient so care can be accessed at home, maintain and enhance Dept. of Health & Human Services (HHS) authority to determine appropriate providers for…

AdvaMed announces The MedTech Conference will be virtual

The MedTech Conference, powered by AdvaMed, announced today that this year’s upcoming conference will be an all-virtual experience.

Originally scheduled to take place in Toronto, the conference will take place on a virtual platform. AdvaMed said in a news release that The MedTech Conference event in 2022 will now be hosted in Toronto.

Beginning in September, registrants for the event will have access to on-demand sessions, which will be released every week through Oct. 7. Additionally, a number of simulcast sessions will be available for viewing between Oct. 5 and Oct. 7, with sessions available on-demand through late October.

The conference’s MedTech Connect partnering platform will be open in August so participants will be able to view other users and begin requesting networking meetings.

“The MedTech Conference is the premier annual gathering of our industry, and it is more important than ever that we show, despite the challenges pr…

Support grows for return of medtech reps to hospitals

Twenty-six more medical and surgical societies and healthcare associations have endorsed guidelines for the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic.

The guidance, released in May by AdvaMed, the Association of periOperative Registered Nurses (AORN) and the American Hospital Association (AHA), builds on the April 17 joint statement by AHA, AORN, the American College of Surgeons and the American Society of Anesthesiologists on the resumption of elective surgeries.

The guidance outlines ways to support the collaboration between healthcare personnel and medtech representatives as healthcare facilities consider when and how to safely resume elective surgeries paused during the pandemic.

Several medical device companies, especially those in orthopedics, have suffered major drops in sales since the Centers for Medicare and Medicaid Services (CMS) recommended in March that healthcare providers postp…

Poll: Patients want to return to the doctor

AdvaMed said polling data confirmed that nearly half of American adults surveyed said they or someone in their household postponed or skipped medical care as a result of COVID-19.

The poll, released yesterday by the Kaiser Family Foundation showed that 48% of those adults or adults in their household had to put off medical care during the pandemic. It also revealed that 68% of those who postponed care expect to receive that care in the next three months, while 11% of respondents reported worsened health as a result of the delay in care.

“We already knew that too many patients have been going without the care that is absolutely vital to their health, and what this poll confirms is that patients themselves are anxious and ready to continue the care that was put on pause because of COVID-19,” AdvaMed president & CEO Scott Whitaker said in a news release. “It’s time for these essential medical procedures to resume. Last week, we joined AORN and AHA in releasing…

Groups release guidance on medtech reps’ return to hospitals

A handful of medical organizations released guidelines today on the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic.

The guidance released today by AdvaMed, the Association of periOperative Registered Nurses (AORN) and the American Hospital Association (AHA) builds on the April 17 joint statement by AHA, AORN, the American College of Surgeons, and the American Society of Anesthesiologists on the resumption of elective surgeries.

Several medical device companies, especially those in orthopedics, have suffered major drops in sales since the Centers for Medicare and Medicaid Services (CMS) recommended in March that healthcare providers postpone elective procedures until further notice to preserve personal protective equipment. The CMS decision followed one by the American College of Surgeons calling for hospitals to “minimize, postpone or cancel” elective procedures until the coronavirus (COVID-19) outbreak s…